2017 Form 10-K Financial Statement

#000070084118000006 Filed on March 08, 2018

View on sec.gov

Income Statement

Concept 2017 2016 Q4 2016 Q1
Revenue $186.7M $39.70M $47.41M
YoY Change 5.83% -11.94% -3.86%
Cost Of Revenue $138.4M $29.55M $33.72M
YoY Change 6.9% -8.44% -6.31%
Gross Profit $48.39M $10.14M $13.69M
YoY Change 2.89% -20.76% 2.78%
Gross Profit Margin 25.91% 25.55% 28.88%
Selling, General & Admin $40.39M $9.334M $10.93M
YoY Change 0.8% -10.78% 5.3%
% of Gross Profit 83.46% 92.01% 79.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.757M $388.0K $390.0K
YoY Change 11.98% -10.6% 25.81%
% of Gross Profit 3.63% 3.82% 2.85%
Operating Expenses $48.11M $9.334M $11.31M
YoY Change 20.08% -10.78% 5.7%
Operating Profit $280.0K $422.0K $2.380M
YoY Change -92.69% -77.86% -9.16%
Interest Expense -$500.0K -$130.0K -$150.0K
YoY Change 0.0% -23.53% 400.0%
% of Operating Profit -178.57% -30.81% -6.3%
Other Income/Expense, Net -$525.0K -$128.0K $0.00
YoY Change -0.57% -26.44% -100.0%
Pretax Income -$1.660M $294.0K $2.110M
YoY Change -148.4% -83.03% -22.43%
Income Tax -$2.255M $184.0K -$870.0K
% Of Pretax Income 62.59% -41.23%
Net Earnings $2.010M $110.0K $2.980M
YoY Change 14.33% -88.57% 73.26%
Net Earnings / Revenue 1.08% 0.28% 6.29%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.17 $0.01 $0.24
COMMON SHARES
Basic Shares Outstanding 12.00M 12.30M
Diluted Shares Outstanding 12.12M 12.43M

Balance Sheet

Concept 2017 2016 Q4 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.900M $300.0K $1.000M
YoY Change 866.67% -93.33% -84.38%
Cash & Equivalents $2.900M $279.0K $985.0K
Short-Term Investments
Other Short-Term Assets $3.700M $2.700M $5.100M
YoY Change 12.12% -12.9% 59.38%
Inventory
Prepaid Expenses
Receivables $49.10M $45.17M $50.95M
Other Receivables $0.00 $4.295M $7.481M
Total Short-Term Assets $55.60M $53.07M $64.53M
YoY Change 4.71% -17.5% -11.09%
LONG-TERM ASSETS
Property, Plant & Equipment $3.400M $4.052M $4.698M
YoY Change -17.07% -16.16% 42.49%
Goodwill $12.33M $11.63M
YoY Change 5.98% 13.76%
Intangibles $171.0K $252.0K
YoY Change -38.04% 29.9%
Long-Term Investments
YoY Change
Other Assets $2.400M $300.0K $200.0K
YoY Change 1100.0% -50.0% -80.0%
Total Long-Term Assets $17.70M $12.71M $12.11M
YoY Change 5.99% 1.56% 6.25%
TOTAL ASSETS
Total Short-Term Assets $55.60M $53.07M $64.53M
Total Long-Term Assets $17.70M $12.71M $12.11M
Total Assets $73.30M $69.83M $81.34M
YoY Change 5.01% -14.5% -6.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.30M $12.10M $16.90M
YoY Change -10.74% 0.0% 17.36%
Accrued Expenses $7.800M $6.300M $8.600M
YoY Change 8.33% -16.0% 10.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.20M $23.71M $26.63M
YoY Change -6.33% 12.55% 12.68%
LONG-TERM LIABILITIES
Long-Term Debt $27.30M $11.20M $21.00M
YoY Change 90.91% -25.33% 5.0%
Other Long-Term Liabilities $1.400M $800.0K $1.000M
YoY Change 600.0% -46.67% 25.0%
Total Long-Term Liabilities $28.70M $12.00M $22.00M
YoY Change 97.93% -27.27% 5.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.20M $23.71M $26.63M
Total Long-Term Liabilities $28.70M $12.00M $22.00M
Total Liabilities $51.20M $38.58M $49.13M
YoY Change 32.64% 2.63% 10.64%
SHAREHOLDERS EQUITY
Retained Earnings -$67.89M -$69.65M
YoY Change 13.35% 10.67%
Common Stock $736.0K $728.0K
YoY Change 3.52% 2.97%
Preferred Stock
YoY Change
Treasury Stock (at cost) $14.62M $10.37M
YoY Change 81.93% 37.67%
Treasury Stock Shares $2.764M $2.063M
Shareholders Equity $22.00M $31.26M $32.20M
YoY Change
Total Liabilities & Shareholders Equity $73.30M $69.83M $81.34M
YoY Change 5.01% -14.5% -6.8%

Cashflow Statement

Concept 2017 2016 Q4 2016 Q1
OPERATING ACTIVITIES
Net Income $2.010M $110.0K $2.980M
YoY Change 14.33% -88.57% 73.26%
Depreciation, Depletion And Amortization $1.757M $388.0K $390.0K
YoY Change 11.98% -10.6% 25.81%
Cash From Operating Activities $5.071M $4.450M $4.990M
YoY Change -56.42% -55.37% 66.33%
INVESTING ACTIVITIES
Capital Expenditures $1.040M -$70.00K -$240.0K
YoY Change 22.93% -95.51% 71.43%
Acquisitions $763.0K
YoY Change
Other Investing Activities -$760.0K -$20.00K $530.0K
YoY Change -3900.0% -97.5%
Cash From Investing Activities -$1.803M -$90.00K $290.0K
YoY Change 116.97% -96.17% -307.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $365.0K
YoY Change -91.43%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -826.0K -4.330M -8.980M
YoY Change -92.85% -18.61% 84.77%
NET CHANGE
Cash From Operating Activities 5.071M 4.450M 4.990M
Cash From Investing Activities -1.803M -90.00K 290.0K
Cash From Financing Activities -826.0K -4.330M -8.980M
Net Change In Cash 2.442M 30.00K -3.700M
YoY Change -424.73% -98.7% 85.0%
FREE CASH FLOW
Cash From Operating Activities $5.071M $4.450M $4.990M
Capital Expenditures $1.040M -$70.00K -$240.0K
Free Cash Flow $4.031M $4.520M $5.230M
YoY Change -62.64% -60.8% 66.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 rcmt Annual Depreciation Rate
AnnualDepreciationRate
0.2
CY2017Q4 rcmt Business Combinations Acquisitions With Contingent Consideration Outstanding
BusinessCombinationsAcquisitionsWithContingentConsiderationOutstanding
6
CY2016 rcmt Business Combinations Increase To Contingent Payment Estimates
BusinessCombinationsIncreaseToContingentPaymentEstimates
285000
CY2017 rcmt Business Combinations Increase To Contingent Payment Estimates
BusinessCombinationsIncreaseToContingentPaymentEstimates
781000
CY2016 rcmt Busniess Combination Estimated Contingent Payments
BusniessCombinationEstimatedContingentPayments
139000
CY2017 rcmt Busniess Combination Estimated Contingent Payments
BusniessCombinationEstimatedContingentPayments
1773000
CY2017Q4 rcmt Estimated Future Contingent Consideration Payments
EstimatedFutureContingentConsiderationPayments
2091000
CY2017Q4 rcmt Estimated Future Contingent Consideration Payments Current
EstimatedFutureContingentConsiderationPaymentsCurrent
741000
CY2017Q4 rcmt Estimated Future Contingent Consideration Payments Year Three
EstimatedFutureContingentConsiderationPaymentsYearThree
725000
CY2017Q4 rcmt Estimated Future Contingent Consideration Payments Year Two
EstimatedFutureContingentConsiderationPaymentsYearTwo
625000
CY2017Q4 rcmt Future Grants Of Options Or Shares
FutureGrantsOfOptionsOrShares
332232
CY2016Q4 rcmt Future Grants Of Options Or Shares
FutureGrantsOfOptionsOrShares
619266
CY2017 rcmt Gain Loss Related To Litigation Settlement And Office Closure
GainLossRelatedToLitigationSettlementAndOfficeClosure
-1447000
CY2016 rcmt Gain Loss Related To Litigation Settlement And Office Closure
GainLossRelatedToLitigationSettlementAndOfficeClosure
-1283000
CY2017Q4 rcmt Liabilities Net
LiabilitiesNet
1700000
CY2016Q4 rcmt Liabilities Net
LiabilitiesNet
2500000
CY2017 rcmt Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeitures Cashless Exercise Weighted Average Exercise Price
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresCashlessExerciseWeightedAverageExercisePrice
6.10
CY2017 rcmt Sharebased Compensation Arrangement By Sharebased Payment Award Options Forfeitures Cashless Exercises
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsForfeituresCashlessExercises
5083
CY2017 rcmt Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Issued Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsIssuedNumberOfShares
0
CY2017 us-gaap Advertising Expense
AdvertisingExpense
700000
CY2016 us-gaap Advertising Expense
AdvertisingExpense
643000
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
770000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
901000
CY2017 rcmt Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
1294000
CY2016 rcmt Vesting Of Restricted Stock Units
VestingOfRestrictedStockUnits
473000
CY2017 rcmt Write Off Of Fully Depreciated Property And Equipment
WriteOffOfFullyDepreciatedPropertyAndEquipment
458000
CY2016 rcmt Write Off Of Fully Depreciated Property And Equipment
WriteOffOfFullyDepreciatedPropertyAndEquipment
2705000
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8634000
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8154000
CY2017Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
4661000
CY2016Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
6776000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46080000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45170000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4563000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3318000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2395000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2578000
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
104540000
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
115607000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
901000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
770000
CY2017 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
3061000
CY2016 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
9877000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
279000
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
967000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1402000
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
66000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80000
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40000
CY2017Q4 us-gaap Assets
Assets
73279000
CY2016Q4 us-gaap Assets
Assets
69831000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
55639000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
53071000
CY2017Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
14194000
CY2016Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12708000
CY2017 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
781000
CY2016 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
285000
CY2017Q4 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
4100000
CY2016Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1800000
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1231000
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
2091000
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
741000
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1061000
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1350000
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
170000
CY2017 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1040000
CY2016 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
846000
CY2017 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
594000
CY2016 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
434000
CY2017Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1841000
CY2016Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2018000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
985000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2851000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2572000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-706000
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
996546
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1327211
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.05
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15017522
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14716940
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12194350
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11953080
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
751000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
736000
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2193000
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2025000
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Concentration</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">During the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2017</div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">, Sikorsky Aircraft represented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.4%</div> of the Company&#x2019;s revenues. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> other client accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> or more of total revenues during the year. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2017 </div>the following clients represented more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.0%</div> of the Company&#x2019;s accounts receivable, net: New York City Board of Education was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.9%</div> and New York Power Authority was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11.9%.</div> As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2017, </div>New York Power Authority total accounts receivable balance (including transit accounts receivable) was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.0%</div> of the total of accounts receivable, net and transit accounts receivable.&nbsp; <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> other customer accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> or more of the Company&#x2019;s accounts receivable, net or total accounts receivable balance (including transit accounts receivable). The Company&#x2019;s five, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twenty</div> largest customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37.9%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">51.4%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">65.2%,</div> respectively, of the Company&#x2019;s revenues for the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2017.</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">During the fiscal year ended <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> client accounted for more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.0%</div> of total revenues. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>the following clients represented more than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10.0%</div> of the Company&#x2019;s accounts receivable, net: New York Power Authority was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.6%.</div> As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>New York Power Authority total accounts receivable balance (including transit accounts receivable of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.5</div> million) was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8.4</div> million or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17.0%</div> of the total of accounts receivable, net and transit accounts receivable.&nbsp; <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> other customer accounted for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> or more of the Company&#x2019;s accounts receivable, net or total accounts receivable balance (including transit accounts receivable). The Company&#x2019;s five, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twenty</div> largest customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31.8%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47.7%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60.8%,</div> respectively, of the Company&#x2019;s revenues for the fiscal year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016.</div></div></div></div></div></div></div></div></div>
CY2017 us-gaap Construction Revenue
ConstructionRevenue
26100000
CY2016 us-gaap Construction Revenue
ConstructionRevenue
27300000
CY2017 us-gaap Cost Of Services
CostOfServices
138350000
CY2016 us-gaap Cost Of Services
CostOfServices
129418000
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-471000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
688000
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
237000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-3000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-116000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1087000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
118000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
402000
CY2017 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
477000
CY2016 us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
588000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1841000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
372000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
197000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-23000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2139000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
457000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1466000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1550000
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-495000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
108000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3224000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1168000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1758000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
2189000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2501000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
53000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
323000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
435000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
394000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
235000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
451000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
382000
CY2017Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
206000
CY2016Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
100000
CY2017Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
503000
CY2016Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
750000
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
326000
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
466000
CY2017Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
431000
CY2016Q4 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
234000
CY2017Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
215000
CY2016Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
212000
CY2017 us-gaap Depreciation
Depreciation
1691000
CY2016 us-gaap Depreciation
Depreciation
1489000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1757000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1569000
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1757000
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1569000
CY2017 us-gaap Dividends Cash
DividendsCash
12194000
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
87000
CY2016Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
CY2017 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
87000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.17
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.14
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
130000
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
46000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
9.204
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.468
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7780000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7185000
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
400000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1415000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-128000
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-245000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3302000
CY2017 us-gaap Fiscal Period
FiscalPeriod
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">The Company follows a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">52/53</div> week fiscal reporting calendar ending on the Saturday closest to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31. </div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">Both of the fiscal years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2017 (</div>fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>) and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 (</div>fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>) were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">52</div>-week reporting years.</div></div></div></div></div></div></div>
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
65000
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
11000
CY2017 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-369000
CY2016Q1 us-gaap Goodwill
Goodwill
11630000
CY2016Q4 us-gaap Goodwill
Goodwill
12325000
CY2017Q4 us-gaap Goodwill
Goodwill
11685000
CY2016 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2017 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
3478000
CY2017 us-gaap Gross Profit
GrossProfit
48387000
CY2016 us-gaap Gross Profit
GrossProfit
47030000
CY2017 us-gaap Gross Transaction Volume
GrossTransactionVolume
38900000
CY2016 us-gaap Gross Transaction Volume
GrossTransactionVolume
49700000
CY2017 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2016 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-1660000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3430000
CY2017 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2016 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2255000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1544000
CY2017 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
1000000
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1015000
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2017 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
2861000
CY2016 us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-92000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
17000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-83000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1123000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
458000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
186000
CY2017 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-39000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-45000
CY2017 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
198000
CY2016 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-248000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
263000
CY2017 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
603000
CY2016 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
522000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
927000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-318000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-290000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
459000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5427000
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-182000
CY2016 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
185000
CY2017 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2336000
CY2016 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-463000
CY2017 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
CY2016 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
15000
CY2017 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
483000
CY2016 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1473000
CY2017 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-2160000
CY2016 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-2254000
CY2017 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1330000
CY2016 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-3220000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
293000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1228000
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
121860
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
120790
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1695000
CY2017 us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
12000
CY2016 us-gaap Operating Leases Income Statement Sublease Revenue
OperatingLeasesIncomeStatementSubleaseRevenue
0
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
105000
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
171000
CY2017 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-590000
CY2016 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-539000
CY2017 us-gaap Interest Paid Net
InterestPaidNet
500000
CY2016 us-gaap Interest Paid Net
InterestPaidNet
464000
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3696000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3186000
CY2017Q4 us-gaap Liabilities
Liabilities
51248000
CY2016Q4 us-gaap Liabilities
Liabilities
38576000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
73279000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69831000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22188000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
23713000
CY2017Q4 us-gaap Litigation Reserve
LitigationReserve
100000
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
27279000
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
14311000
CY2017 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
10000000
CY2017 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td style="width:18pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:left;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">CONTINGENCIES </div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business.<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">&nbsp; As such, the Company is required to assess the likelihood of any adverse outcomes to these matters as well as potential ranges of losses and possible recoveries.&nbsp; The Company <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be covered by insurance as it pertains to some or all of these matters. A determination of the amount of the provision required for these commitments and contingencies, if any, which would be charged to earnings, is made after careful analysis of each matter.&nbsp; Once established, a provision <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>change in the future due to new developments or changes in circumstances, and could increase or decrease the Company&#x2019;s earnings in the period that the changes are made.&nbsp; Asserted claims in these matters sought approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10.0</div> million in damages (including <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.3</div> million in counter claims described below) as of </div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2017</div></div><div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2017, </div>the Company had an accrual of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.1</div> million for any such liabilities. </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">The Company has a dispute with a customer that is a major utility in the United States. Essentially, the customer has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> paid the balance of accounts receivable the Company believes are owed to the Company. The Company recently compelled arbitration with this customer. The total amount due from this customer is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6.9</div> million<div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">, subject to an upward adjustment following disclosures by the customer in the arbitration. Additionally, as part of the arbitration process, the customer has asserted counter claims of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9.3</div> million. The Company also believes these counter claims were retaliatory in nature. Prior to the arbitration, the customer had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> asserted any claims. The Company believes these asserted claims have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> merit and were merely asserted as a strategy to reduce the Company&#x2019;s claims in any arbitration award or potential settlement agreement. The Company believes that its accounts receivable balance, subject to reserves, is collectible. Furthermore, the Company believes that this arbitration will conclude sometime in fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> While the Company believes the customer&#x2019;s counter claims to be frivolous and without merit, it can give <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurances that it will ultimately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have to pay all or a portion of such claims.</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:justify;">The Company is also subject to other pending legal proceedings and claims that arise from time to time in the ordinary course of its business, which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be covered by insurance.</div></div>
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-826000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11556000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1803000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-831000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5071000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11635000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
2010000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
1758000
CY2017 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
1896000
CY2016 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
695000
CY2017 us-gaap Number Of Reporting Units
NumberOfReportingUnits
3
CY2017 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
48107000
CY2016 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
43200000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
280000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
3830000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
6607000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
3036000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
304000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
516000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1056000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8009000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7370000
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40385000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40063000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
770000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3446000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4052000
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3706000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3327000
CY2017 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
183000
CY2016 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
267000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-525000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-528000
CY2017Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3002000
CY2016Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4295000
CY2017 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1694000
CY2016 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
993000
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
365000
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4257000
CY2017 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12194000
CY2016 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
763000
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1040000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
846000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2017 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Reclassification</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">Certain prior year amounts have been <div style="display: inline; font-family:'Times New Roman', Times, serif;font-size:10pt;">reclassified for consistency with the current year presentation. These reclassifications had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> effect on the reported results or operations.</div></div></div></div></div></div></div></div>
CY2017 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
92918000
CY2016 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
83605000
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
65000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15000
CY2017 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
394000
CY2016 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
368000
CY2017 us-gaap Professional Fees
ProfessionalFees
259000
CY2016 us-gaap Professional Fees
ProfessionalFees
0
CY2017 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
210000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
616000
CY2017 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
79950000
CY2016 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
90294000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65878000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67888000
CY2017 us-gaap Revenues
Revenues
186737000
CY2016 us-gaap Revenues
Revenues
176448000
CY2017 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
2600000
CY2016 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
3600000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
901000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
15000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.33
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
177280
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
268211
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
27000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.47
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
17000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
25000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
9.81
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
6000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
42000
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44500
CY2016Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.12
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.27
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.62
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
0
CY2017Q4 us-gaap Share Price
SharePrice
6.25
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
15000
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
0
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
0
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.33
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2500
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
11917
CY2016 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
368000
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
394000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
15000
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
65000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
22031000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
31255000
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
32203000
CY2017 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
1200000
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
372000
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
537000
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2823172
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2763860
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
14987000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
14622000
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4257000
CY2017 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
365000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
628000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
628000
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12117201
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12423348
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11995341
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12302558

Files In Submission

Name View Source Status
0000700841-18-000006-index-headers.html Edgar Link pending
0000700841-18-000006-index.html Edgar Link pending
0000700841-18-000006.txt Edgar Link pending
0000700841-18-000006-xbrl.zip Edgar Link pending
exhibit10v.htm Edgar Link pending
exhibit10x.htm Edgar Link pending
exhibit21.htm Edgar Link pending
exhibit231.htm Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit321.htm Edgar Link pending
exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10k123017.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rcmt-20171230.xml Edgar Link completed
rcmt-20171230.xsd Edgar Link pending
rcmt-20171230_cal.xml Edgar Link unprocessable
rcmt-20171230_def.xml Edgar Link unprocessable
rcmt-20171230_lab.xml Edgar Link unprocessable
rcmt-20171230_pre.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending